Ponce, Pilar, NONE. S.
HRN: 04-43-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/20/2022
10/27/2022
IV
2.25 G
Q6
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes